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ABSTRACT
To study the requirements for the in vitro formation of the
protein p3-dAMP complex, the first step in 029 DNA replication,
extracts from B. subtilis infected with 029 mutants in genes 2,
3, 5, 6 and 17, involved in DNA synthesis, have been used. The
formation of the initiation complex is completely dependent on
the presence of a functional gene 2 product, in addition to pro-
tein p3 and 029 DNA-protein p3 as template. ATP is also requi-
red, although it can be replaced by other nucleotides. The pro-
ducts of genes 5, 6 and 17 do not seem to be needed in the for-
mation of the initiation complex.
Inhibitors of the host DNA polymerase III, DNA gyrase or RNA
polymerase had no effect on the formation of the protein p3-dAMP
complex, suggesting that these proteins are not involved in the
initiation of 029 DNA replication. ddATP or aphidicolin, inhibi-
tors of DNA chain elongation, had also no effect on the forma-
tion of the initiation complex.
INTRODUCTION
Bacillus subtilis phage 029 contains a linear, double-stran-
ded DNA of about 18 000 base pairs (1) with a protein covalently
bound to the two 5' ends (2-5). This protein is the product of
gene 3, p3 (2) and is linked to the DNA by a phosphoester bond
between the OH group of a serine residue and 5'dAMP, the termi-
nal nucleotide at both 5' ends (6). The nucleotide sequence of
the DNA region shown to contain gene 3 has been determined and a
molecular weight of 31 049 can be deduced for protein p3 (7,8).
Genes 2, 3, 5, 6 and 17 are involved in 029 DNA replication (9-
12). Shift-up experiments using ts mutants showed that genes 2
and 3 are involved in an initiation step, and genes 5 and 6 in
elongation or maturation steps (12).
Phage 029 DNA replication starts at either DNA end, non si-
multaneously, and proceeds by a mechanism of strand-displacement
© I R L Press Limited, Oxford, England.
Volume 1 1 Number 5 1983
1 309
Nucleic Acids Research
(13-15). Adenovirus DNA, which also has a protein covalently
linked to the 5' ends (16,17), replicates by a similar strand-
displacement mechanism (18,19).
An important problem in the replication of a linear DNA such
as that of phage 029 and adenovirus, is how the DNA chain is ini-
tiated at the 5' ends. In the model proposed for the initiation
of 029 (12-14) and adenovirus DNA replication (16) a free mole-
cule of the terminal protein primes replication by reaction with
the dNTP at the 5' ends and formation of a protein-dNMP covalent
complex that provides the 3'OH group needed for elongation by
the DNA polymerase. This mechanism is suDported by the finding
of the formation in vitro of a covalent complex between urotein
p3 and dAMP (20,21) and between the orecursor of the adenovirus
terminal protein and dCMP, the nucleotide at the 5' ends of ade-
novirus DNA (22-26).
With the use of extracts from B. subtilis infected with 029
mutants in genes 2, 3, 5, 6 and 17 we show in this paper that the
in vitro formation of the protein p3-dAMP initiation complex re-
quires, besides protein p3, the product of gene 2. The products
of genes 5, 6 or 17 do not seem to be involved in vitro in the
initiation step. The results obtained using drugs which inhibit
host enzymes needed for bacterial DNA replication suggest that
host DNA polymerase III, DNA gyrase and RNA polymerase are not
required in the formation in vitro of the p3-dAMP initiation
complex.
MATERIALS AND METHODS
Bacterial strains and phage
B. subtilis F25-1, lacking DNA polymerase I activity (27),
obtained from N. Cozzarelli and B. subtilis liONA try spoA (28),
were used as non-permissive hosts. B. subtilis MO-101-P spoA thr
{met } su444 (29), was used as permissive host.
The suppressor-sensitive (sus) mutants of Dhage 029, sus2
(513), sus2(515), sus3(91), sus6(626) and susl7(112) were from
the collection of Moreno et al. (28), and susl7(741) from that of
Reilly et al. (30). The temperature-sensitive (ts) mutants ts2
(98) and tsS(17) were from the collection of Talavera et al.(31).
1310
Nucleic Acids Research
Materials
{a-32P}dATP (410 Ci/mmol) was obtained from The Radiochemi-
cal Centre, Amersham. Micrococcal nuclease was from Worthington.
Nalidixic acid, novobiocine, rifampicin, chloramDhenicol, nucleo-
side 5'-triphosphates, deoxynucleoside 5'-triphosphates and 6,
y-methyleneadenosine 5'-triphosphate (AMP-PCP) were from Sigma
Chemical Co. and a, y-imidoadenosine 5'-triphosphate (AMP-PNP)
and 2',3'-dideoxyadenosine-5'-triphosphate (ddATP) were from P-L
Biochemicals, Inc. Aphidicolin and 6-(p-hydroxyphenylazo)uracil
were a gift from Imperial Chemical Industries. $29 DNA-protein
p3 complex was prepared as described (20).
Growth of cells and preparation of extracts
B. subtilis F25-1 su , lacking DNA polymerase I activity,was
grown at 370C and infected with wild-type phage 029 or with dif-
ferent sus mutants as described (20). In the case of ts mutants,
parallel infections were carried out at 300C and 440C. The cells
were harvested at either 45 min postinfection (experiments at
37°C or 44 C) or 55 min postinfection (experiments at 30 C).
Lysates were prepared from frozen cells as described (20).
After centrifugation for 30 min at 40 000 x g, the supernatant
was precipitated with ammonium sulfate to 70% saturation and dia-
lyzed (S40-fraction). The pellet was extracted by phase Darti-
tion with polyethyleneglycol 8000-dextrane 500 (PEG-fraction)as
described (20). When indicated, the supernatant was passed, prior
to the ammonium sulfate precipitation, through a DEAE-cellulose
column, to remove nucleic acids (DEAE-fraction) (20).
Assay for formation of protein p3-dAMP covalent complex (initia-
tion reaction)
The standard incubation mixture for the initiation reaction
contained, in a final volume of 0.05 ml, 50 mM Tris-HCl, pH 7.5,
10 mM MgCl2, 1 mM ATP, 0.25 pM {a-32P}dATP (5 pCi) and about 75
pg of protein from the different fractions. When indicated, 0.5
ig of 029 DNA-protein p3 complex was added as template. After
incubation for 20 min at 30°C the samples were processed as des-
cribed (20), including the treatment with micrococcal nuclease.
The samples were subjected to electrophoresis in polyacrylamide
slab gels containing 10% acrylamide and 0.1% SDS (32). The gels
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were dried and autoradiographed with intensifying screens at
- 700C.
RESULTS
Requirement of the productsof genes 2 and 3 for the in vitro
formation of the p3-dAMP initiation complex
When the DEAE-fraction from B. subtilis infected with mutant
sus3(91) was incubated in vitro with {or-32P}dATP and $29 DNA-
protein p3 as described in Materials and Methods, no formation
of a 32P-labelled band corresponding to the p3-dAMP initiation
complex was seen in the gels (Fig. 1A and B, lane a; see also
lane g in Figs. 2, 3 and 4). This is the expected result since
no intact protein p3 should be synthesized in the sus3-infected
cells. Neither the S40- nor the PEG-fraction, prepared from B.
subtilis infected with mutant sus2(513), both containing protein
p3 (20), gave rise to the formation of the 32P-labelled p3-dAMP
band in the initiation reaction (Fig. 1A, lanes b and c). How-
ever, they were complemented with the DEAE-fraction from sus3-
infected cells (Fig. 1A, lanes d and e). Mixing the S40- and
PEG-fractions from the sus2-infected extracts did not restore
the ability to form the p3-dAMP initiation complex (results not
shown). To determine whether the results obtained with mutant
sus2(513) were specific of this particular mutant, due to some
cryptic mutation, or other mutants in gene 2 behaved in a simi-
lar way, the PEG-fraction was prepared from B. subtilis infected
with mutant sus2 (515) and tested in the formation of the p3-dAMP
complex. As shown in Fig. 1B (lanes b-d), this fraction was only
active when complemented with the DEAE-fraction from sus3-infec-
ted cells and it required the addition of $29 DNA-protein p3 as
template. Moreover, the S40-fraction prepared from cells infec-
ted at 440C with mutant ts2(98) did not give rise to the forma-
tion of the initiation complex unless supplemented with the
DEAE-fraction from the sus3-infected cells and 029 DNA-protein
p3 as template (Fig. 2, lanes d-f). When the infection with mu-
tant ts2(98) was done at 300C initiation complex was formed
(Fig. 2, lanes a-c). All the above results show that the gene
2 product is required, in addition to protein p3, in the forma-
tion of the protein p3-dAMP initiation complex.
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Fig. 1. Effect of sus mutations in genes 2 or 3 on the in vi-
tro formation of the protein P3-dAMP initiation complex. A.
Fractions (S40 or PEG) from B. subtilis infected with mutant
sus2(513) or DEAE-fraction from B. subtilis infected with mu-
tant sus3(91) were incubated with {a-JZPPXATP, ATP and 029 DNA-
protein p3 (except where indicated) as described in Materials
and Methods. After treatment with micrococcal nuclease the sam-
ples were subjected to SDS-polyacrylamide gel electrophoresis.
Lanes : a. sus3(91); b. sus2(513), S40-fraction. c. sus2(513),
PEG-fraction. d. sus2(513), S40-fraction + sus3(91). e. sus2
(513), PEG-fraction + sus3(91). f. Markers of known molecular
weight (the figures indicate K daltons). B. PEG-fraction from
cells infected with mutant sus2(515) or DEAE-fraction from cells
infected with mutant sus3(9TFwere incubated as in A. Lanes : a.
sus3 (91); b. sus2 (515); c. sus2 (515) + sus3 (91); d. as c without
m29 DNA-protein p3; e. Markers of known molecular weight (the
figures indicate K daltons).
Effect of mutations in genes 5, 6 and 17 on the formation of the
initiation complex
Using available conditional-lethal mutants of phage 029 we
tried to answer the question if any other known genes, needed in
vivo for DNA replication, are involved in the formation of the
initiation complex, in vitro. Fig. 3 shows that the PEG-fraction
prepared from cells infected at 300C or 440C with mutant ts5 (17)
was active in the formation of the 32P-labelled p3-dAMP complex
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Fig. 2. Effect of a ts mutation in gene 2 on the in vitro for-
mation of the protein p3-dAMP initiation complex. S40-fraction
prepared from B. subtilis infected at 300C or 440C with mutant
ts2(98) was incubated for 20 min at 300C with {a-32P}dATP, ATP
and $29 DNA-protein p3 (except where indicated) as described in
Materials and Methods. When indicated, DEAE-fraction from B.sub-
tilis infected with mutant sus3(91) was added. After treatment
with micrococcal nuclease the samples were subjected to SDS-po-
lyacrylamide gel electrophoresis. a. ts2(98) -30°C; b. ts2(98) -
300C + sus3(91); c. as b without $29 DNA-protein p3; d. ts2(98)-
44°C; e. ts2(98) -440C + sus3(91); f. as e without $29 DNA-prot-
ein p3; g. sus3(91); h. Markers of known molecular weight (the
figures indicate K daltons).
when supplemented with $29 DNA-protein p3 as a temolate (Fig. 3,
lanes a, b, d and e). The reaction was stimulated when the DEAE-
fraction from sus3-infected cells was added (Fig. 3,lanes c and f.
Figure 4 shows that the PEG-fraction prepared from cells in-
fected with mutants sus6(626) or susl7(741) is active in the
formation of the initiation complex when $29 DNA-protein p3 is
added as a template (lanes a and d). No reaction takes place in
the absence of the template (lanes b and e) and no stimulation
is observed when, in addition, the DEAE-fraction from sus3-in-
fected cells is added (lanes c and f). Similar results to those
reported for mutant susl7(741) were obtained when other mutant
in gene 17, sus17(112), was used (not shown).
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Fig. 3. Effect of a ts mutation in gene 5 on the in vitro forma-
tion of the protein p3-dAMP initiation complex. PEG-fraction pre-
pared from B. subtilis infected at 300C or 440C with mutant ts5
(17) was incubated for 20 min at 300C with {a-32P}dATP, ATP and$29 DNA-protein p3 (except where indicated) as described in Ma-
terials and Methods. When indicated, DEAE-fraction from B. sub-
tilis infected with mutant sus3(91) was added. After treatment
with micrococcal nuclease the samples were subjected to SDS-po-
lyacrylamide gel electrophoresis. a. ts5(17) - 30°C; b. as a
without 029 DNA-protein p3; c. ts5(17V--300C + sus3(91); d. ts5
(17) - 440C; e. as d without 29 DNA-protein p3; f. ts5 - 440C+
sus3(91); g. sus3(91); h. Markers of known molecular weight (the
figures indicate K daltons).
Effect of inhibitors of replication, transcription and transla-
tion on the formation of the initiation complex
As an approach to search for host functions needed for the
initiation step, different inhibitors of DNA replication were
tested for their effect on the formation of the initiation com-
plex. Table 1 shows that neither nalidixic acid nor novobiocine,
inhibitors of the A and B subunits of the DNA gyrase, respecti-
vely (33), affected the formation of the p3-dAMP complex. Aphi-
dicolin, which has been reported to inhibit $29 DNA synthesis
in vivo (34) and 6-(p-hydroxyphenylazo)uracil, an inhibitor of
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Fig. 4. Effect of a sus mutation in genes 6 or 17 on the in vi-
tro formation of the protein p3-dAMP initiation complex. PEG-
fraction prepared from B. subtilis infected with mutants sus6
(626) or susl7(741) was incubated for 20 min at 300C with TaE32p}
dATP, ATP and $29 DNA-protein p3 (except where indicated) as
described in Materials and Methods. When indicated, DEAE-fract-
ion from B. subtilis infected with mutant sus3(91) was added.
After treatment with micrococcal nuclease the samples were sub-
jected to SDS-polyacrylamide gel electrophoresis. a. sus6(626);
b. sus6(626) without 029 DNA-protein p3; c. sus6(626) + sus3(91);
d. susl7(741); e. susl7(741) without $29 DNA-protein p3;f. sus17
(74TF+ sus3(91); g. sus3(91); h. Markers of known molecular
weight (the figures indicate K daltons).
the B. subtilis DNA polymerase III (35,36) had no effect on the
formation of the initiation complex. A concentration of ddATP in
320-fold excess over the dATP, essentially did not inhibit the
initiation reaction. Rifampicin and chloramphenicol, inhibitors
of transcription and translation, respectively, had no effect on
the formation of the initiation complex.
ATP requirement for the formation of the initiation complex
As already reported (20) and shown in Table 2, ATP is requi-
red for the formation of the p3-dAMP initiation complex, the ma-
ximal activity being obtained at a concentration of 1 mM (not
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Table 1. Effect of inhibitors of reolication, transcription and
translation on the formation of the p3-dAMP initiation
complex
S40-fraction prepared from 029 wild-type infected cells was in-
cubated with {a-32p}dATP and ATP in the absence or presence of
the different inhibitors as described in Materials and Methods.
The 32P-labelled p3-dAMP band obtained by SDS-polyacrylamide gel
electrophoresis was quantitated both by densitometry of the au-
toradiographs obtained by exposure under linear conditions and
by counting the band sliced out of the gel. The two measurements
were in good agreement. 100% corresponds to the incorporation of
0.5 fmol of 32P-dAMP.
shown), with a stimulation of about 20-fold over the control
without nucleotide. ATP can be replaced by GTP, CTP, UTP, dGTP,
dCTP and dTTP in the initiation reaction; the activity with dCTP
is even higher than with ATP. ADP was also active in the forma-
tion of the initiation complex, although less efficiently than
the ribo- and deoxyribonucleoside triphosphates indicated above.
AMP was essentially inactive. To try to determine whether or not
ATP hydrolysis is required, the non-hydrolyzable analogs of ATP,
AMP-PNP and AMP-PCP were tested in the in vitro initiation reac-
tion. The activity with 1 mM AMP-PNP was about 19% of that ob-
1317
Inhibitor Concentration Activity, %
None 100
Nalidixic acid 100 pg/ml 106
200 ig/ml 117
Novobiocin 50 ig/ml 95
100 ig/ml 117
Aphidicolin 40 pg/ml 87
100 ag/ml 97
6-(p-hydroxyphenylazo) 25 ag/ml 106
uracil 50 ig/ml 104
ddATP 40 VM 82
80 pM 80
Rifampicin 10 .g/ml 105
20 jg/ml 91
Chloramphenicol 50 ig/ml 97
200 ig/ml 95
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Table 2. Effect of ATP and other nucleotides in the formation
of the p3-dAMP initiation complex
S40-fraction prepared from 029 wild-tyDe infected cells, passed
through a Sephadex G50 column to remove endogenous nucleotides,
was incubated with {a-32P}dATP in the absence or presence of the
different nucleotides as described in Materials and Methods. The
amount of labelled p3-dAMP complex obtained by SDS-polyacrylami-
de gel electrophoresis was quantitated as described in Table 1.
100% corresponds to the incorporation of 0.75 fmol of 2p-dAMp.
tained with 1 mM ATP. AMP-PCP at a concentration of 1 mM was
much less active, being the formation of the initiation complex
10% of the amount obtained with 1 mM ATP, only slightly higher
than the reaction which takes place in the absence of nucleotide.
1318
Addition Concentration, mM Activity, %
ATP 1 100
0,1 49
GTP 1 75
0,1 149
CTP 1 64
0,1 97
UTP 1 88
0,1 110
dGTP 1 85
0,1 132
dCTP 1 200
0,1 213
dTTP 1 42
0,1 120
ADP 1 42
0,1 6
AMP 1 4
0,1 3
AMP-PNP 1 19
0,1 6
AMP-PCP 1 10
0,1 6
None 4
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DISCUSSION
Protein p3, present in extracts from 029-infected B. subti-
lis, reacts in vitro with dATP in the presence of 029 DNA-prot-
ein p3 as a template and ATP, forming a p3-dAMP covalent complex
(20). Therefore, as shown in this paper, extracts from sus3-in-
fected B. subtilis should not give rise in vitro to the forma-
tion of the p3-dAMP initiation complex.
To determine whether any other viral protein is needed for
the initiation reaction, extracts from B. subtilis infected with
sus or ts mutants in genes known to be required for 029 DNA re-
plication were tested. When extracts from cells infected with
two different sus mutants in gene 2 were used, no formation of
the p3-dAMP complex occurred unless supplemented with a DNA-free
fraction from sus3-infected cells and 029 DNA-protein p3 as tem-
plate. Moreover, extracts prepared from cells infected at 440C
with a ts2 mutant were inactive in the formation of the initia-
tion complex, but they could be complemented by addition of the
sus3-fraction. As expected, extracts from cells infected at 30QC
with the ts2 mutant were active in the formation of the initia-
tion complex, in the absence or presence of the sus3-fraction.
These results indicate that the gene 2 product is required for
the initiation reaction, in agreement with the finding that in
vivo gene 2 is involved in replication in an initiation step
(12). The gene 2 product has been characterized as a protein of
molecular weight 67 000 (37) and probably corresponds to the
open reading frame 7 in the sequence of the left early region of
029 DNA (38), which would code for a protein of molecular weight
66 500. The gene 2 product was shown to be required in vivo for
the attachment of phage 029 DNA to the host cell membrane (39,
40). In addition to this role, it is likely that the gene 2 pro-
duct has some other role in the initiation reaction since mem-
branes do not seem to be required in vitro for the formation of
the initiation complex (20,21).
Extracts prepared from cells infected with sus mutants in
genes 6 and 17 gave rise to the formation of the p3-dAMP initia-
tion complex, suggesting that the corresponding gene products
are not involved in the initiation reaction. Regarding the gene
17 product it has to be pointed out that the two mutants in gene
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17 available, used in the experiments, are leaky (11; our unpu-
blished results) and produce a small amount of synthesis of vi-
ral DNA. The possibility that some protein p17 had been synthe-
sized or that a bacterial protein replaces the gene 17 product
cannot be ruled out. In the case of the reaction with extracts
from cells infected at 300C or 440C with mutant ts5(17) initia-
tion complex was formed, although stimulation by addition of the
sus3-fraction occurred. A similar stimulation by addition of the
sus3-fraction was also observed with a DEAE-fraction prepared
from wild-type-infected cells (unpublished results). The above
results suggest that the gene 5 product is not required in the
formation of the initiation complex, although it is possible that
the mutation in protein p5, synthesized in the cells infected at
440C with mutant ts5(17), is reversible and therefore, the prot-
ein could be active in the in vitro experiment carried out at
300C. Unfortunately, there is essentially no formation of ini-
tiation complex in vitro at 420C (unpublished results) and the
above possibility cannot be excluded. Also, no sus mutation in
gene 5 is presently available.
Inhibitors of DNA gyrase, DNA polymerase III or RNA polymer-
ase were tested in vitro and shown not to affect the formation
of the initiation complex. Aphidicolin, reported to inhibit 929
DNA replication in vivo (34) and ddATP, an inhibitor of DNA
elongation, had little effect on the formation of the initiatian
complex. The last result suggests not only, as it has been shown
(20), that the initiation and elongation are different events in
929 DNA replication, but that the initiation reaction is very
selective for the 2'deoxy,3'-hydroxy nucleotide, possibly be-
cause of the function of the initiation complex as a supplier of
a free 3'-OH group for elongation.
ATP is needed in the initiation reaction, although it can be
replaced by all ribo- and deoxyribonucleoside triphosphates tes-
ted. Similarly, in the formation of the initiation complex bet-
ween the adenovirus preterminal protein and dCMP, ATP can be re-
placed by dATP, dGTP, GTP and UTP (41). ADP, but not AM?, was
also active in the formation of the 029 initiation complex. The
low stimulation obtained with the non-hydrolyzable analogs of
ATP, AMP-PNP and AMP-PCP suggests that ATP hydrolysis might be
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required in the initiation reaction; however, further studies
with the purified proteins will be needed to answer this ques-
tion. No ATPase activity has been detected in protein p3 puri-
fied (Prieto et al., in preparation) from extracts from E. coli
transformed with the recombinant plasmid pKC30 Al containing
gene 3 (42), but other protein(s) involved in the initiation
reaction, such as protein p2, might have that activity.
The precursor of the adenovirus terminal protein has been
purified in a functional form and it was shown to copurify with
a DNA polymerase activity different from DNA polymerases a,6 or
y (43). More recently, Lichy et al. (44) could separate the ade-
novirus terminal protein precursor from the associated DNA poly-
merase activity and showed that both proteins are involved in
the initiation reaction. In addition, a host factor has been pu-
rified and shown to stimulate the formation of the initiation
complex in vitro, being an absolute requirement when the adeno-
virus DNA binding protein is present (45). DNA oolymerase acti-
vity does not copurify with protein p3 (Prieto et al., in ore-
paration). Whether or not the gene 2 product has DNA polymerase
activity remains an open question. Cloning of gene 2 to over-
produce and purify the protein is in progress.
ACKNOWLEDGEMENTS
This investigation has been aided by Grant 1 ROl G27242-03
from the National Institutes of Health and by grants from the
Comisi6n Asesora para el Desarrollo de la Investigaci6n Cienti-
fica y Tecnica and Fondo de Investigaciones Sanitarias. L.B.,
J.A.G. and M.A.P. were Fellows of Plan de Formaci6n de Personal
Investigador, Spanish Research Council and Fondo de Investiga-
ciones Sanitarias, respectively.
*Present address: Department of Molecular Genetics Antibi6ticos, S.A., Bravo Murillo 38,
Madrid 3, Spain
REFERENCES
1. Sogo, J.M., Inciarte, M.R., Corral, J., Vifiuela, E. and Sa-
las, M. (1979) J. Mol. Biol. 127, 411-436.
2. Salas, M., Mellado, R.P., Vinuela, E. and Sogo, J.M. (1978)
J. Mol. Biol. 119, 269-291.
1321
Nucleic Acids Research
3. Harding, N., Ito, J. and David, G.S. (1978) Virology 84,
279-292.
4. Yehle, D.C. (1978) J. Virol. 27, 776-783.
5. Ito, J. (1978) J. Virol. 28, 895-904.
6. Hermoso, J.M. and Salas, M. (1980) Proc. Natl. ACad. Sci.
USA 77, 6425-6428.
7. Mellado, R.P. and Salas, M. (1982) Nucl. Acids Res. 10,
5773-5784.
8. Escarmis, C. and Salas, M. (1982) Nucl. Acids Res. 10,5785-
5798.
9. Talavera, A., Salas, M. and Viniuela, E. (1972) Eur. J. Bio-
chem. 31, 367-371.
10. Carrascosa, J.L., Camacho, A., Moreno, F., Jim6nez, F., Me-
llado, R.P., Vifnuela, E. and Salas, M. (1976) Eur. J. Bio-
chem. 66, 229-241.
11. Hagen, E.W., Reilly, B.E., Tosi, M.E. and Anderson, D.L.
(1976) J. Virol. 19, 501-517.
12. Mellado, R.P., Pefnalva, M.A., Inciarte, M.R. and Salas, M.
(1980) Virology 104, 84-96.
13. Inciarte, M.R., Salas, M. and Sogo, J.M. (1980) J. Virol.
34, 187-199.
14. Harding, N.E. and Ito, J. (1980) Virology 104, 323-338.
15. Sogo, J.M., Garcia, J.A., Pefialva, M.A. and Salas, M.(1982)
Virology 116, 1-18.
16. Rekosh, D.M.K., Russell, W.C., Bellet, A.J.D. and Robinson,
A.J. (1977) Cell 11, 283-295.
17. Carusi, E.A. (1977) Virology 76, 390-394.
18. Lechner, R.L. and Kelly, T.J.,Jr. (1977) Cell 12, 1007-1020.
19. Winnacker, E.L. (1978) Cell 14, 761-773.
20. Pefialva, M.A. and Salas, M. (1982) Proc. Natl. Acad. Sci.
USA 79, 5522-5526.
21. Shib, M., Watabe, K. and Ito, J. (1982) Biochem. Biophys.
Res. Commun. 105, 1031-1036.
22. Lichy, J.H., Horwitz, M.S. and Hurwitz, J. (1981) Proc.
Natl. Acad. Sci. USA 78, 2678-2682.
23. Pincus, S., Robertson, W. and Rekosh, D. (1981) Nucl.Acids
Res. 9, 4919-4937.
24. Challberg, M.D., Ostrove, J.M. and Kelly, T.J.,Jr. (1982)
J. Virol. 41, 265-270.
25. Tamanoi, F. and Stillman, B.W. (1982) Proc. Natl. Acad.Sci.
USA 79, 2221-2225.
26. Sussenbach, J.S. and Van der Vliet, P.C. (1982) in Develop-
ments in Mol. Virology, vol. 2 (Y. Becker, ed.), in press.
27. Gass, K.B. and Cozzarelli, N.R. (1973) J. Biol. Chem. 248,
7688-7700.
28. Moreno, F., Camacho, A., Vinuela, E. and Salas, M. (1974)
Virology 62, 1-16.
29. Mellado, R.P., Vifnuela, E. and Salas, M. (1976) Eur. J.
Biochem. 65, 213-223.
30. Reilly, B.E., Zeece, V.M. and Anderson, D.L. (1973) J. Vi-
rol. 11, 756-760.
31. Talavera, A., Jim6nez, F., Salas, M. and Vifnuela, E. (1971)
Virology 46, 586-595.
32. Laemmli, U.K. (1970) Nature (London) 227, 680-685.
33. Sugino, A. and Bott, K.F. (1980) J. Bacteriol. 141, 1331-
1339.
1322
Nucleic Acids Research
34. Hirokawa, H., Matsumoto, K. and Ohashi, M. (1981) in Mole-
cular Cloning and Gene Regulation (A.T. Ganesan, ed..)
Stanford Univ., Palo Alto, pp 74-82.
35. Gass, K., Low, R.L. and Cozzarelli, N.R. (1973) Proc. Natl.
Acad. Sci. USA 70, 103-107.
36. Mackenzie, J.M., Neville, M.M., Wriaht, G.E. and Brown, N.
C. (1973) Proc. Natl. Acad. Sci. USA 70, 512-516.
37. McGuire, J.C., Pane, J.J. and Barrow-Carraway, J. (1974)
J. Virol. 13, 690-698.
38. Yoshikawa, H. and Ito, J. (1982) Gene 17, 323-335.
39. Ivarie, R.D. and Pane, J.J. (1973) Virology 52, 351-362.
40. McGuire, J.C., Gilpatrick, M.W. and Pane, J.J. (1977) Vi-
rology 78, 234-240.
41. De Jong, P.J., Kwant, M.M., Van Driel, W., Jansz, H.S. and
Van der Vliet, P.C. (1982) Virology 123,
42. Garcia, J.A., Pastrana, R., Prieto, I. and Salas, M. Gene,
in press.
43. Enomoto, T., Lichy, J.H., Ikeda, J.E. and Hurwitz, J.(1981)
Proc. Natl. Acad. Sci. USA 78, 6779-6783.
44. Lichy, J.H., Field, J., Horwitz, M.S. and Hurwitz, J. (1982)
Proc. Natl. Acad. Sci. USA 79, 5225-5229.
45. Nagata, K., Guggenheimer, R.A., Enomoto, T., Lichy, J.H.
and Hurwitz, J. (1982) Proc. Natl. Acad. Sci. USA 79,6438-
64 42.
1323
